Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nam Hung Viet Vaccine and Biological Products Joint Stock Company is a leading Vietnamese healthcare distributor and a founding member of the NAVIVA GROUP. Established in 2006, the company specializes in the marketing, distribution, and commercialization of human vaccines, diagnostic biological products, laboratory reagents, and medical analyzers. Headquartered in Ho Chi Minh City, it operates GDP-compliant cold chain warehouses and serves over 3,000 healthcare institutions across Vietnam, including hospitals, CDCs, and vaccination centers. The company maintains strategic partnerships with major global manufacturers such as GSK, Abbott, and Serum Institute of India, as well as leading domestic vaccine producers like VABIOTECH and IVAC.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nam Hung Viet Vaccine and Biological Products.